Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains one of the leading causes of mortality worldwide, necessitating the continuous exploration of innovative therapeutic approaches. The development and evaluation of novel drug delivery systems for targeted cancer therapy have emerged as a promising strategy to enhance treatment efficacy while minimizing systemic toxicity. This thesis presents a comprehensive investigation into the design, development, and evaluation of advanced drug delivery systems tailored for targeted cancer therapy. The introduction provides a background of the study, highlighting the pressing need for more effective and targeted cancer treatments. The problem statement underscores the limitations of current cancer therapies, emphasizing the demand for novel drug delivery systems to address these challenges. The objectives of the study are outlined, focusing on the development and evaluation of targeted drug delivery systems for enhanced cancer treatment outcomes. The limitations and scope of the study are delineated, providing a clear framework for the research methodology. Chapter two comprises a detailed literature review encompassing ten key areas related to drug delivery systems for cancer therapy. The review explores the principles of targeted drug delivery, various nanocarrier systems, targeting strategies, and recent advancements in the field. The chapter synthesizes existing knowledge to inform the development of novel drug delivery systems for targeted cancer therapy. Chapter three delves into the research methodology, outlining the experimental design, materials, and methods employed in the development and evaluation of novel drug delivery systems. Key components include the synthesis of nanocarrier systems, drug loading techniques, in vitro and in vivo evaluation methods, and data analysis procedures. The chapter elucidates the systematic approach followed to achieve the research objectives effectively. Chapter four presents a comprehensive discussion of the findings derived from the development and evaluation of novel drug delivery systems for targeted cancer therapy. The results encompass the characterization of nanocarrier systems, drug release profiles, cellular uptake studies, in vivo efficacy assessments, and safety profiles. The discussion critically analyzes the implications of the findings in advancing targeted cancer therapy and highlights potential areas for future research. Finally, chapter five encapsulates the conclusion and summary of the thesis, synthesizing the key findings, implications, and contributions to the field of targeted cancer therapy. The conclusion reflects on the significance of the research outcomes in advancing personalized cancer treatment approaches and outlines future directions for research and clinical translation. Overall, this thesis contributes to the growing body of knowledge on innovative drug delivery systems for targeted cancer therapy, with the potential to revolutionize cancer treatment paradigms and improve patient outcomes.